Atomera Provides Fourth Quarter and Fiscal 2025 Results
Rhea-AI Summary
Atomera (NASDAQ:ATOM) reported fourth-quarter and fiscal 2025 results and a corporate update on Feb 12, 2026. Key technical milestones include a manufacturability breakthrough of MST on GAA transistors, a top‑20 customer running GaN wafers with MST, and the GaN‑on‑Silicon concept advancing to the Power America proposal phase.
Financial highlights: Q4 2025 net loss was $4.4M (loss per share $0.14); fiscal 2025 revenue was $65,000 and net loss was $20.2M. Cash and equivalents were $19.2M at year‑end.
Positive
- Manufacturability of MST on GAA demonstrated (Q4 2025)
- Top‑20 semiconductor customer running GaN wafers with MST
- GaN‑on‑Silicon concept advanced to Power America proposal phase
Negative
- Fiscal 2025 revenue declined to $65,000 (↓52% YoY)
- Cash and short‑term investments fell to $19.2M as of Dec 31, 2025 (↓28% YoY)
News Market Reaction
On the day this news was published, ATOM declined 2.85%, reflecting a moderate negative market reaction. Argus tracked a peak move of +55.2% during that session. Argus tracked a trough of -2.7% from its starting point during tracking. Our momentum scanner triggered 85 alerts that day, indicating high trading interest and price volatility. This price movement removed approximately $4M from the company's valuation, bringing the market cap to $127M at that time. Trading volume was exceptionally heavy at 41.5x the daily average, suggesting significant selling pressure.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Market Reality Check
Peers on Argus
Peers showed mixed moves: INTT −1.13%, ASYS −11.69%, SMTK −9.66% while AXTI +3.84% and ICHR +3.46%, suggesting no clear sector-wide direction relative to ATOM’s flat pre-news price.
Historical Context
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Jan 29 | Earnings date announcement | Neutral | +8.9% | Set timing and webcast details for Q4 and FY 2025 results. |
| Jan 27 | Technology funding progress | Positive | +16.6% | GaN-on-Silicon concept advanced to proposal phase in funding program. |
| Nov 05 | AI materials research | Neutral | -0.7% | Released survey research on AI compute needs and materials innovation. |
| Oct 28 | Q3 2025 earnings | Negative | -1.5% | Reported higher net loss, larger EBITDA loss, and declining cash balances. |
| Oct 28 | Executive hire | Positive | -1.5% | Named new VP of Sales to drive commercial growth in advanced materials. |
Past news has produced mixed reactions, with some positive technology updates drawing strong gains while operational and earnings items have sometimes seen modest declines or divergences.
Over the last six months, Atomera issued several updates including Q3 2025 results on Oct 28, 2025 highlighting increased losses and cash use, and a sales leadership hire the same day. A research piece on AI and materials innovation followed on Nov 5, 2025. In late January 2026, a GaN-on-Silicon funding milestone and the Q4/FY 2025 earnings date drove notable gains of 16.55% and 8.93%, respectively. Today’s full-year results build directly on that setup.
Market Pulse Summary
This announcement combines technical milestones in Gate-All-Around and GaN platforms with detailed Q4 and fiscal 2025 results. Losses narrowed in Q4, but full-year figures still showed revenue of only $65,000 and a net loss of $20.2M, with cash at $19.2M on Dec 31, 2025. Investors may track future revenue traction, adjusted EBITDA trends, and conversion of current customer activity into more meaningful licensing income.
Key Terms
gate-all-around technical
gan-on-silicon technical
adjusted ebitda financial
non-gaap financial
AI-generated analysis. Not financial advice.
LOS GATOS, CA / ACCESS Newswire / February 12, 2026 / Atomera Incorporated (NASDAQ:ATOM), a semiconductor materials and technology licensing company, today provided a corporate update and announced financial results for the fourth quarter and fiscal year ended December 31, 2025.
Recent Company Highlights
Achieved technical breakthrough demonstrating manufacturability of MST on Gate-All-Around structures
First commercial customer running wafers on GaN with MST
GaN-on-Silicon concept paper advances to proposal phase in Power America funding program
Management Commentary
"The results we are seeing with MST for GAA transistors are inspiring and together with our OEM partner we are presenting groundbreaking results to some of the most demanding customers in the industry. We also have a top 20 semiconductor company running wafers on GaN, demonstrating industry pull for the innovative work that, up to now, we have done in university and government labs," said Scott Bibaud, President and CEO. "From bleeding edge transistors to enabling new materials to run next generation data centers, Atomera is providing innovations that are in high demand for today's markets."
Financial Results
The Company incurred a net loss of (
For fiscal year 2025, revenue was
The Company had
The total number of shares outstanding was 32.4 million as of December 31, 2025.
Fourth Quarter and Fiscal Year 2025 Results Webinar
Atomera will host a live video webinar today to discuss its financial results and recent progress.
Date: Thursday, Feb. 12, 2026
Time: 2:00 p.m. PT (5:00 p.m. ET)
Webcast: Accessible at https://ir.atomera.com
Note about Non-GAAP Financial Measures
In addition to the unaudited results presented in accordance with generally accepted accounting principles, or GAAP, in this press release, Atomera presents adjusted EBITDA, which is a non-GAAP financial measure. Adjusted EBITDA is determined by taking net loss and eliminating the impacts of interest, depreciation, amortization and stock-based compensation. Our definition of adjusted EBITDA may not be comparable to the definitions of similarly-titled measures used by other companies. We believe that this non-GAAP financial measure, viewed in addition to and not in lieu of our reported GAAP results, provides useful information to investors by providing a more focused measure of operating results. This metric is used as part of the Company's internal reporting to evaluate its operations and the performance of senior management. A table reconciling this measure to the comparable GAAP measure is available in the accompanying financial tables below.
About Atomera Incorporated
Atomera Incorporated is a semiconductor materials and technology licensing company focused on deploying its proprietary, silicon-proven technology into the semiconductor industry. Atomera has developed Mears Silicon Technology™ (MST®), which increases performance and power efficiency in semiconductor transistors. MST can be implemented using equipment already deployed in semiconductor manufacturing facilities and is complementary to other nano-scaling technologies already in the semiconductor industry roadmap. More information can be found at www.atomera.com.
Safe Harbor
This press release contains forward-looking statements concerning Atomera Incorporated, including statements regarding the prospects for the semiconductor industry generally and the ability of our MST technology to significantly improve semiconductor performance. Those forward-looking statements involve known and unknown risks, uncertainties and other factors that could cause actual results to differ materially. Among those factors are: (1) the fact that, to date, we have only recognized minimal engineering services and licensing revenues thus subjecting us to all the risks inherent in an early-stage enterprise; (2) the risk that licensees or JDA customers do not advance to royalty-based manufacturing and distribution licenses; (3) our ability to add other licensees and/or JDA customers; (4) risks related to our ability to raise sufficient capital, as and when needed, to pursue the further development, licensing and commercialization of our MST technology; (5) our ability to protect our proprietary technology, trade secrets and knowhow and (6) those other risks disclosed in the section "Risk Factors" included in our Annual Report on Form 10-K filed with the SEC on March 4, 2025. We caution readers not to place undue reliance on any forward-looking statements. We do not undertake, and specifically disclaim any obligation, to update or revise such statements to reflect new circumstances or unanticipated events as they occur.
-- Financial Tables Follow --
Atomera Incorporated
Balance Sheets
(in thousands, except per share data)
December 31, | December 31, | |||||||
2025 | 2024 | |||||||
(Unaudited) | ||||||||
ASSETS | ||||||||
Current assets: | ||||||||
Cash and cash equivalents | $ | 19,210 | $ | 25,778 | ||||
Short-term investments | - | 995 | ||||||
Accounts receivable | - | 6 | ||||||
Interest receivable | 54 | 73 | ||||||
Prepaid expenses and other current assets | 338 | 240 | ||||||
Total current assets | 19,602 | 27,092 | ||||||
Property and equipment, net | 60 | 59 | ||||||
Long-term prepaid maintenance and supplies | - | 91 | ||||||
Security deposit | 14 | 14 | ||||||
Operating lease right-of-use asset | 884 | 280 | ||||||
Financing lease right-of-use-asset | 533 | 1,588 | ||||||
Total assets | $ | 21,093 | $ | 29,124 | ||||
LIABILITIES AND STOCKHOLDERS' EQUITY | ||||||||
Current liabilities: | ||||||||
Accounts payable | $ | 608 | $ | 492 | ||||
Accrued expenses | 168 | 239 | ||||||
Accrued payroll related expenses | 650 | 1,328 | ||||||
Current operating lease liability | 147 | 260 | ||||||
Current financing lease liability | 420 | 1,253 | ||||||
Deferred revenue | 7 | 4 | ||||||
Total current liabilities | 2,000 | 3,576 | ||||||
Long-term operating lease liability | 712 | 22 | ||||||
Long-term financing lease liability | - | 449 | ||||||
Total liabilities | 2,712 | 4,047 | ||||||
Commitments and contingencies | - | - | ||||||
Stockholders' equity: | ||||||||
Preferred stock | - | - | ||||||
Common stock: | 32 | 31 | ||||||
Additional paid-in capital | 260,043 | 246,565 | ||||||
Other comprehensive income | - | 1 | ||||||
Accumulated deficit | (241,694 | ) | (221,520 | ) | ||||
Total stockholders' equity | 18,381 | 25,077 | ||||||
Total liabilities and stockholders' equity | $ | 21,093 | $ | 29,124 | ||||
Atomera Incorporated
Statements of Operations
(in thousands, except per share data)
Three Months Ended | Year Ended | |||||||||||||||||||
December 31, | September 30, | December 31, | December 31, | |||||||||||||||||
2025 | 2025 | 2024 | 2025 | 2024 | ||||||||||||||||
(Unaudited) | (Unaudited) | (Unaudited) | (Unaudited) | |||||||||||||||||
Revenue | $ | 50 | $ | 11 | $ | 23 | $ | 65 | $ | 135 | ||||||||||
Cost of revenue | (131 | ) | (128 | ) | (13 | ) | (321 | ) | (123 | ) | ||||||||||
Gross margin | (81 | ) | (117 | ) | 10 | (256 | ) | 12 | ||||||||||||
Operating expenses | ||||||||||||||||||||
Research and development | 2,740 | 3,304 | 2,823 | 12,303 | 11,029 | |||||||||||||||
General and administrative | 1,505 | 2,165 | 1,811 | 7,806 | 7,266 | |||||||||||||||
Selling and marketing | 286 | 207 | 248 | 758 | 1,053 | |||||||||||||||
Total operating expenses | 4,531 | 5,676 | 4,882 | 20,867 | 19,348 | |||||||||||||||
Loss from operations | (4,612 | ) | (5,793 | ) | (4,872 | ) | (21,123 | ) | (19,336 | ) | ||||||||||
Other income (expense) | ||||||||||||||||||||
Interest income | 195 | 232 | 213 | 931 | 779 | |||||||||||||||
Accretion income | - | - | 26 | 6 | 178 | |||||||||||||||
Other income, net | 1 | - | 1 | 72 | 73 | |||||||||||||||
Interest expense | (9 | ) | (12 | ) | (25 | ) | (60 | ) | (129 | ) | ||||||||||
Total other income (expense), net | 187 | 220 | 215 | 949 | 901 | |||||||||||||||
Net loss | $ | (4,425 | ) | $ | (5,573 | ) | $ | (4,657 | ) | $ | (20,174 | ) | $ | (18,435 | ) | |||||
Net loss per common share, basic and diluted | $ | (0.14 | ) | $ | (0.17 | ) | $ | (0.16 | ) | $ | (0.65 | ) | $ | (0.68 | ) | |||||
Weighted average number of common shares outstanding, basic and diluted | 31,590 | 31,128 | 28,934 | 30,844 | 27,217 | |||||||||||||||
Atomera Incorporated
Reconciliation to Non-GAAP Adjusted EBITDA
(Unaudited)
Three Months Ended | Year Ended | |||||||||||||||||||
December 31, | September 30, | December 31, | December 31, | |||||||||||||||||
2025 | 2025 | 2024 | 2025 | 2024 | ||||||||||||||||
Net loss (GAAP) | $ | (4,425 | ) | $ | (5,573 | ) | $ | (4,657 | ) | $ | (20,174 | ) | $ | (18,435 | ) | |||||
Depreciation and amortization | 13 | 11 | 12 | 48 | 54 | |||||||||||||||
Stock-based compensation | 1,334 | 1,342 | 949 | 4,963 | 3,867 | |||||||||||||||
Interest income | (195 | ) | (232 | ) | (213 | ) | (931 | ) | (779 | ) | ||||||||||
Accretion income | - | - | (26 | ) | (6 | ) | (178 | ) | ||||||||||||
Other income, net | (1 | ) | - | (1 | ) | (72 | ) | (73 | ) | |||||||||||
Interest expense | 9 | 12 | 25 | 60 | 129 | |||||||||||||||
Net loss non-GAAP Adjusted EBITDA | $ | (3,265 | ) | $ | (4,440 | ) | $ | (3,911 | ) | $ | (16,112 | ) | $ | (15,415 | ) | |||||
Investor Contact:
Bishop IR
Mike Bishop
(415) 894-9633
investor@atomera.com
SOURCE: Atomera, Inc.
View the original press release on ACCESS Newswire
FAQ
What technical milestones did Atomera (ATOM) announce on Feb 12, 2026?
How did Atomera (ATOM) perform financially in fiscal 2025?
What was Atomera's (ATOM) net loss and EPS for Q4 2025?
How much cash did Atomera (ATOM) have at year‑end 2025 and how did it change year‑over‑year?
Will Atomera (ATOM) discuss results with investors and when is the webcast?
Does Atomera (ATOM) report non‑GAAP measures and what do they mean?
